腹主动脉瘤腔内修复术中患者的辐射暴露
该回顾性研究分析了2015年1月至2020年12月间99例择期标准腹主动脉瘤腔内修复术(EVAR)患者,评估患者特征和术中复杂因素与辐射暴露的关联。中位透视时间19.6分钟,中位剂量面积乘积(DAP)86,311 mGy cm2,中位有效剂量(ED)23.2 mSv。BMI、术中≥2项额外操作和对侧支架释放后导管插入时间(CGCT)是DAP和ED的独立正向预测因素。
要点
- BMI、术中≥2项额外操作和CGCT是EVAR患者辐射暴露的独立预测因素。
- 增加辐射暴露的主要术中因素是CGCT。
- 接受最高等效剂量的器官为肾脏、小肠、活跃骨髓、结肠和胃。
核心结论
- 患者相关和手术相关因素如BMI、术中≥2项额外操作和CGCT可预测EVAR患者的辐射暴露,表现为更高的DAP和ED水平。
- 增加辐射暴露的主要术中因素是CGCT。
- 这些数据对于更好地管理EVAR期间的辐射暴露可能具有重要意义。
研究设计与样本
- 回顾性分析2015年1月至2020年12月间的择期标准EVAR手术。
- 收集患者特征和术中数据(包括装置类型、内移植物构型、额外操作和对侧支架释放后导管插入时间[CGCT])。
- 以剂量面积乘积(DAP)和透视时间作为辐射暴露的测量指标,并使用PCXMC 2.0软件计算有效剂量(ED)和器官剂量。
- 采用描述性统计、单变量和多变量线性回归分析辐射暴露增加的预测因素。
- 共纳入99例患者,其中男性90.9%,平均年龄74±7岁。
主要发现
- EVAR适应证最常见为腹主动脉瘤(93.9%),其次为穿透性主动脉溃疡(2.0%)、局限性夹层(2.0%)或肾下腹主动脉瘤亚急性破裂(2.0%)。
- 中位透视时间为19.6分钟(四分位距[IQR] 14.1-29.4),中位DAP为86,311 mGy cm2(IQR 60,160-130,385)。
- 93例患者(93.9%)的中位ED为23.2 mSv(IQR 17.0-34.8)。
- DAP和ED与体重指数(BMI)和CGCT呈正相关。
- 肾脏、小肠、活跃骨髓、结肠和胃是EVAR期间接受最高等效剂量的器官。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To investigate associations between patient characteristics, intraprocedural complexity factors, and radiation exposure to patients during endovascular abdominal aortic aneurysm repair (EVAR). METHODS: Elective standard EVAR procedures between January 2015 and December 2020 were retrospectively analyzed. Patient characteristics and intraprocedural data (i.e., type of device, endograft configuration, additional procedures, and contralateral gate cannulation time [CGCT]) were collected. Dose area product (DAP) and fluoroscopy time were considered as measurements of radiation exposure. Furthermore, effective dose (ED) and doses to internal organs were calculated using PCXMC 2.0 software. Descriptive statistics, univariable, and multivariable linear regression were applied to investigate predictors of increased radiation exposure. RESULTS: The 99 patients were mostly male (90.9%) with a mean age of 74 ± 7 years. EVAR indications were most frequently abdominal aortic aneurysm (93.9%), penetrating aortic ulceration (2.0%), focal dissection (2.0%), or subacute rupture of infrarenal abdominal aortic aneurysm (2.0%). Median fluoroscopy time was 19.6 minutes (interquartile range [IQR], 14.1-29.4) and median DAP was 86,311 mGy cm2 (IQR, 60,160-130,385). Median ED was 23.2 mSv (IQR, 17.0-34.8) for 93 patients (93.9%). DAP and ED were positively correlated with body mass index (BMI) and CGCT. Kidneys, small intestine, active bone marrow, colon, and stomach were the organs that received the highest equivalent doses during EVAR. Higher DAP and ED values were observed using the Excluder endograft, other bi- and tri-modular endografts, and EVAR with ≥2 additional procedures. Multivariable linear regression analysis revealed that BMI, ≥2 additional procedures during EVAR, and CGCT were independent positive predictors of DAP and ED levels after accounting for endograft type. CONCLUSIONS: Patient-related and procedure-related factors such as BMI, ≥2 additional procedures during EVAR, and CGCT resulted predictors of radiation exposure for patients undergoing EVAR, as quantified by higher DAP and ED levels. The main intraprocedural factor that increased radiation exposure was CGCT. These data can be of importance for better managing radiation exposure during EVAR.
引用
- Mandigers TJ, Fulgheri I, Pugliese G, et al. Patients' Radiation Exposure During Endovascular Abdominal Aortic Aneurysm Repair. Ann Vasc Surg. 2023. PMID: 37356660. doi:10.1016/j.avsg.2023.06.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。